Home › Glaxo gets OK to expand marketing of inhaler drug
 

Keywords :   


Glaxo gets OK to expand marketing of inhaler drug

2015-05-01 00:31:09| Biotech - Topix.net

GlaxoSmithKline plc says it has received U.S. approval to sell its once-a-day respiratory inhaler Breo Ellipta for a new use in asthma patients ages 18 and older. The expanded approval from the Food and Drug Administration will help Glaxo replace sales of its best-selling product, Advair, which faces generic competition in Europe and pricing pressures in the U.S. Breo Ellipta was originally approved to treat a form of lung disease.

Tags: marketing expand drug glaxo

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
12.05Is social media worth paying for?
12.05'I'm stuck in my flat due to 4k service charge'
12.05Switzer Ranch staying resilient with long-term outlook
12.05BIF announces Seedstock, Commercial Producer award finalists
11.05Weekly Recap: Hempel, Sherwin-Williams Top This Weeks Stories
11.05LG CHI Color Master Factory Is Awarded Patent
11.05AgriWebb raises $7.2m to fuel further innovation in sustainable beef production
11.05YouGov Unveils Americans Skincare Routines
More »